Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses

A methylation and nucleic acid technology, applied in biochemical equipment and methods, disease diagnosis, biomaterial analysis, etc., can solve problems such as maternal and child risks

Inactive Publication Date: 2012-08-22
SEQUENOM INC +1
View PDF31 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these conventional methods are invasive and carry significant risks for both mother and baby

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
  • Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
  • Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0197] In the following examples, 10 paired maternal and placental DNA samples were used to identify differentially methylated regions. These results were confirmed using a mass spectrometry-based quantitative methylation assay. First, genomic DNA was extracted from maternal buffy coat and corresponding placental tissue. Next, the methylated fraction of each DNA sample was captured with MBD-FC. See Figure 1-3 . The two tissue sections were labeled with different fluorescent dyes and compared with the Agilent CpG island microarray hybridization. See Figure 4 . This is done by identifying differentially methylated regions that can be used for prenatal diagnosis. Therefore, two criteria were used to select genomic regions as potential enrichment markers: the observed difference in methylation must be present in all tested sample pairs, and the length of the region must be greater than 200 bp.

[0198] DNA preparation and fragmentation

[0199] Genomic DNA (gDNA) from ...

Embodiment 2

[0219] Example 2 describes a non-invasive protocol for detecting the amount of fetal nucleic acid present in a maternal sample (referred to herein as a "fetal quantification method") that can be used to detect or confirm a fetal trait (e.g., fetal sex for RhD compatibility) or Diagnosis of chromosomal abnormalities such as trisomy 21 (both are referred to herein as "methods of methylation-based fetal diagnosis"). Figure 10 shows an embodiment of the fetal quantification method, while Figure 11 One embodiment of a method for methylation-based fetal diagnosis is shown. Both methods use fetal DNA obtained from a maternal sample. Samples contain differentially methylated maternal and fetal nucleic acids. For example, the sample can be maternal plasma or serum. Fetal DNA accounts for approximately 2-30% of the total DNA in maternal plasma. The exact amount of fetal contribution to the total nucleic acid present in a sample varies from pregnancy to pregnancy and can vary based...

Embodiment 3

[0323] Example 3 - Other differentially methylated targets

[0324] Differentially methylated targets not located on chromosome 21

[0325] Additional differentially methylated targets were selected for further analysis based on previous microarray analysis. See Example 1 for a description of the microarray analysis. In microarray screening, differentially methylated regions (DMRs) between placental tissue and PBMCs were defined. Regions were selected for EpiTYPER confirmation based on hypermethylation in placenta relative to PBMC. After selecting the orientation of the change, regions are selected based on statistical significance, with the design regions starting at the highest significance and progressing downward according to significance. These studies were performed in 8 paired PBMC and placenta samples. Additional non-chromosomal 21 targets are provided in Table IB, along with representative genomic sequences for each target in Table 4B.

[0326] Differentially met...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided are compositions and processes that utilize genomic regions that are differentially methylated between a mother and her fetus to separate, isolate or enrich fetal nucleic acid from a maternal sample. The compositions and processes described herein are particularly useful for non-invasive prenatal diagnostics, including the detection of chromosomal aneuplodies.

Description

[0001] Related Patent Applications [0002] This patent application is a continuation-in-part of U.S. Patent Application No. 12 / 561,241, filed September 16, 2009, with the same title as this application, and its attorney docket number is SEQ-6022-UT, which claims the September 16, 2008 U.S. Provisional Patent Application No. 61 / 192,264, filed today, having attorney docket number SEQ-6022-PV. The entire contents of the above patent application, including all text, drawings and tables, are incorporated herein by reference. technical field [0003] This technical section relates to prenatal diagnosis and enrichment methods. Background technique [0004] Noninvasive prenatal testing is becoming an area of ​​rapidly increasing interest. Early detection of pregnancy-related conditions, including complications during pregnancy and genetic defects of the fetus, is critical as it allows for the early medical intervention necessary for the safety of mother and baby. Prenatal diagno...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12N15/117C12N15/10
CPCC12Q1/6804C12Q1/6806C12Q1/6809C12Q2600/154C12Q1/6883C12Q2537/164C12Q2522/101C12Q2565/501C12Q1/6888C12Q1/6879G01N33/5308G01N2800/385
Inventor M·埃里希A·O·H·尼格伦T·J·詹森
Owner SEQUENOM INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com